T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Lockheed Martin
LMT
$140B
| $149M | 0.03% |
772,894
-111,480
| -13% | -$20.7M |
|
|
CBL
502
DELISTED
CBL& Associates Properties, Inc.
CBL
| $148M | 0.03% |
7,636,919
-39,060
| -0.5% | -$735K |
|
503
MakeMyTrip
MMYT
$5.67B
| $148M | 0.03% |
5,696,014
+241,444
| +4% | +$6.61M |
|
|
WAGE
504
DELISTED
WageWorks, Inc.
WAGE
| $147M | 0.03% |
2,281,300
+258,655
| +13% | +$14.4M |
|
505
ScottsMiracle-Gro
SMG
$3.62B
| $147M | 0.03% |
2,355,422
-37,300
| -2% | -$2.22M |
|
506
Alaska Air
ALK
$5.29B
| $147M | 0.03% |
2,453,425
-493,807
| -17% | -$26M |
|
507
Armstrong World Industries
AWI
$7.75B
| $146M | 0.03% |
2,856,030
+836,160
| +41% | +$41.4M |
|
508
Charter Communications
CHTR
$17.9B
| $146M | 0.03% |
874,040
-871,349
| -50% | -$138M |
|
|
AVNS
509
DELISTED
Avanos Medical
AVNS
| $145M | 0.03% |
+3,189,935
| New | +$125M |
|
|
BECN
510
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $144M | 0.03% |
5,178,950
-170,880
| -3% | -$4.64M |
|
511
Trane Technologies
TT
$105B
| $144M | 0.03% |
2,264,983
-191,770
| -8% | -$11.7M |
|
512
Innospec
IOSP
$2.29B
| $143M | 0.03% |
3,352,730
+3,550
| +0.1% | +$145K |
|
|
PF
513
DELISTED
Pinnacle Foods, Inc.
PF
| $142M | 0.03% |
4,019,695
+37,015
| +0.9% | +$1.25M |
|
514
Radian Group
RDN
$4.87B
| $142M | 0.03% |
8,463,098
+286,240
| +4% | +$4.62M |
|
|
LL
515
DELISTED
LL Flooring Holdings, Inc.
LL
| $140M | 0.03% |
2,115,520
-832,909
| -28% | -$48.2M |
|
|
MDSO
516
DELISTED
Medidata Solutions, Inc.
MDSO
| $140M | 0.03% |
2,935,149
+319,049
| +12% | +$13.8M |
|
|
EMC
517
DELISTED
EMC CORPORATION
EMC
| $140M | 0.03% |
4,709,141
-267,230
| -5% | -$7.78M |
|
518
Target
TGT
$69.9B
| $140M | 0.03% |
1,842,706
-217,720
| -11% | -$14.7M |
|
519
Minerals Technologies
MTX
$2.25B
| $140M | 0.03% |
2,013,500
+605,730
| +43% | +$42.1M |
|
|
BLUE
520
DELISTED
bluebird bio
BLUE
| $139M | 0.03% |
117,108
+34,715
| +42% | +$23.2M |
|
|
IPCC
521
DELISTED
Infinity Property & Casualty C
IPCC
| $139M | 0.03% |
1,795,071
| – | – |
|
|
FNGN
522
DELISTED
Financial Engines, Inc.
FNGN
| $138M | 0.03% |
3,767,489
-386,660
| -9% | -$13.4M |
|
|
NATI
523
DELISTED
National Instruments Corp
NATI
| $138M | 0.03% |
4,424,925
-1,953,150
| -31% | -$60.6M |
|
|
PHH
524
DELISTED
PHH Corporation
PHH
| $137M | 0.03% |
5,718,866
+258,700
| +5% | +$6.01M |
|
|
DCT
525
DELISTED
DCT Industrial Trust Inc.
DCT
| $137M | 0.03% |
3,840,989
+75,434
| +2% | +$2.52M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.